Systemic & 
High-throughput
Drug Discovery

FluoSphera is the only company with a suite of systemic and high-throughput in vitro drug discovery solutions that reduce costs and increase speed and effectiveness.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Cost effective. Faster.
Improved drug discovery outcomes.

FluoSphera’s chip-free 3D cell culturing solutions mimic the natural physiology of the human body, its complex biology, and disease states, enabling researchers to study the human response to systemic drug delivery rapidly and precisely.

FluoSphera empowers its customers and partners to de-risk drug discovery

Benefits of Partnering with FluoSphera

Accelerated Drug Discovery

Multiplexing, high-throughput, modular technology allows for individual project customization for rapid evaluation of >1000 compounds with 28 simultaneous readouts.

Reduced Reliance on Animal Testing

Systemic Exposure recapitulates human first-pass liver Drug Metabolism and PharmacoKinetics (DMPK) allowing for early detection of drug systemic effects normally only detected in animal models or patients.

Reduced Pre-clinical Expenditure

Optimizes pre-clinical testing and animal model species selection, reducing unnecessary costs while enhancing the likelihood of clinical trial success.

Things move fast in drug discovery,
so don't get left behind.

Subscribe to our Investor Newsletter to keep up with FluoSphera’s milestones ahead of the next fundraising round

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Find us on social media